Research update – ProQR
In February 2022, ProQR announced a disappointing outcome for their phase 2/3 trial of sepofarsen for Leber congenital amaurosis type 10 (LCA10).
Search results
In February 2022, ProQR announced a disappointing outcome for their phase 2/3 trial of sepofarsen for Leber congenital amaurosis type 10 (LCA10).
We have created Discover Wellbeing to help people affected by inherited sight loss to develop an awareness of emotional wellbeing and the practical skills to adapt to life’s ups and downs.
Join us for an inspiring webinar where young adults living with sight loss share their extraordinary stories and insights.
Dr Graham undertook research into the basic mechanisms of retinal vasculitis, inflammation of the blood vessels in the retina, and is an important cause of poor vision in patients with uveitis, inflammation of the uveal tract.
Back for 2023, the virtual TCS London Marathon lets you join our team close to home and get your marathon medal!
Support Retina UK and take on three of the highest, most iconic peaks in Wales within 24 hours, with The Welsh Three Peaks Challenge.
Take on Ben Nevis and be rewarded with the feeling that you have just hiked the UK’s highest mountain for Retina UK.
Are you affected by inherited sight loss? We are here to help.
Our vision is a world where everyone with inherited sight loss is able to live a fulfilling life.
If you, or a close relative, are living with a genetic sight loss condition, there may be a chance that your children will inherit it.